Does ONASEMNOGENE ABEPARVOVEC-XIOI Cause Hepatic function abnormal? 36 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 36 reports of Hepatic function abnormal have been filed in association with ONASEMNOGENE ABEPARVOVEC-XIOI (Zolgensma). This represents 1.7% of all adverse event reports for ONASEMNOGENE ABEPARVOVEC-XIOI.
36
Reports of Hepatic function abnormal with ONASEMNOGENE ABEPARVOVEC-XIOI
1.7%
of all ONASEMNOGENE ABEPARVOVEC-XIOI reports
0
Deaths
27
Hospitalizations
How Dangerous Is Hepatic function abnormal From ONASEMNOGENE ABEPARVOVEC-XIOI?
Of the 36 reports, 27 (75.0%) required hospitalization, and 8 (22.2%) were considered life-threatening.
Is Hepatic function abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ONASEMNOGENE ABEPARVOVEC-XIOI. However, 36 reports have been filed with the FAERS database.
What Other Side Effects Does ONASEMNOGENE ABEPARVOVEC-XIOI Cause?
Pyrexia (515)
Vomiting (484)
Aspartate aminotransferase increased (331)
Alanine aminotransferase increased (298)
Hepatic enzyme increased (256)
Thrombocytopenia (183)
Platelet count decreased (161)
Liver function test increased (138)
Troponin i increased (126)
Pneumonia (125)
What Other Drugs Cause Hepatic function abnormal?
NIVOLUMAB (1,131)
PEMBROLIZUMAB (1,079)
METHOTREXATE (1,054)
CABOZANTINIB S-MALATE (912)
CYCLOPHOSPHAMIDE (824)
BEVACIZUMAB (769)
PACLITAXEL (603)
LENVATINIB (528)
ATORVASTATIN (520)
CYCLOSPORINE (508)
Which ONASEMNOGENE ABEPARVOVEC-XIOI Alternatives Have Lower Hepatic function abnormal Risk?
ONASEMNOGENE ABEPARVOVEC-XIOI vs ONBREZ
ONASEMNOGENE ABEPARVOVEC-XIOI vs ONDANSETRON
ONASEMNOGENE ABEPARVOVEC-XIOI vs ONFI
ONASEMNOGENE ABEPARVOVEC-XIOI vs OPANA
ONASEMNOGENE ABEPARVOVEC-XIOI vs OPICAPONE